By Terell Wright
Shares of Azenta advanced after the company swung to a profit and posted sales growth in the latest quarter.
Shares rose 12% to $33.51 in late morning trading on Friday, but are still down 33% this year.
The life sciences company said before the open it recorded a fourth-quarter profit of $47.1 million, or $1.02 a share, compared with a loss of $6.6 million, or 14 cents a share, in the same period a year earlier.
Adjusted earnings were 21 cents a share, beating analysts' expectations of 19 cents a share, according to FactSet.
Revenue grew 6% to $159.2 million, ahead of Wall Street's estimate of $156.2 million.
Organic revenue grew 4% driven by higher sales in the company's multiomics segment.
Chief Executive John Marotta said the company simplified its organization, made significant progress enabled by the Azenta Business System, and strengthened its execution, which drove measurable improvements in quality, delivery and productivity in fiscal 2025.
For 2026, the company expects organic revenue growth of 3% to 5%.
Write to Terell Wright at terell.wright@wsj.com
(END) Dow Jones Newswires
November 21, 2025 11:49 ET (16:49 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Comments